Cite
HARVARD Citation
Harding, J. et al. (2021). Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study. Cancer. 127 (24), pp. 4585-4593. [Online].